Cargando…

Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme

Glioblastoma multiforme (GBM) is the most common and aggressive malignant adult primary brain tumor. Despite surgical resection followed by radiotherapy and chemotherapy, the median survival rate is approximately 14 months. Although experimental therapies are in clinical trials for GBM, there is an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Sze Kiat, Pastori, Chiara, Penas, Clara, Komotar, Ricardo J., Ivan, Michael E., Wahlestedt, Claes, Ayad, Nagi G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861620/ https://www.ncbi.nlm.nih.gov/pubmed/29558959 http://dx.doi.org/10.1186/s12943-018-0822-0

Ejemplares similares

Epigenetic pathways and glioblastoma treatment
por: Clarke, Jennifer, et al.
Publicado: (2013)

BET bromodomain proteins are required for glioblastoma cell proliferation
por: Pastori, Chiara, et al.
Publicado: (2014)

Identifying Glioblastoma Gene Networks Based on Hypergeometric Test Analysis
por: Stathias, Vasileios, et al.
Publicado: (2014)

Involvement of long noncoding RNAs in diseases affecting the central nervous system
por: Pastori, Chiara, et al.
Publicado: (2012)

Emerging treatment strategies for glioblastoma multiforme
por: Carlsson, Steven K, et al.
Publicado: (2014)

Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme
por: Chin, Christopher, et al.
Publicado: (2018)

Glioblastoma multiforme of the optic chiasm: A rare case of common pathology
por: Lyapichev, Kirill A., et al.
Publicado: (2016)

Drug Repositioning in Glioblastoma: A Pathway Perspective
por: Tan, Sze Kiat, et al.
Publicado: (2018)

Comprehensive analysis of the transcriptional landscape of the human FMR1 gene reveals two new long noncoding RNAs differentially expressed in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome
por: Pastori, Chiara, et al.
Publicado: (2013)

Long Noncoding RNA HOTAIR as an Independent Prognostic Marker in Cancer: A Meta-Analysis
por: Zhang, Shenghong, et al.
Publicado: (2014)

HOTAIR is a therapeutic target in glioblastoma
por: Zhou, Xuan, et al.
Publicado: (2015)

Drug and disease signature integration identifies synergistic combinations in glioblastoma
por: Stathias, Vasileios, et al.
Publicado: (2018)

Prognostic Relevance of Cytochrome c Oxidase in Primary Glioblastoma Multiforme
por: Griguer, Corinne E., et al.
Publicado: (2013)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Visualizing the structure and motion of the long noncoding RNA HOTAIR
por: Spokoini-Stern, Rachel, et al.
Publicado: (2020)

Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform
por: Tang, Xiangjun, et al.
Publicado: (2020)

The APC/C Ubiquitin Ligase: From Cell Biology to Tumorigenesis
por: Penas, Clara, et al.
Publicado: (2012)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

Long Noncoding RNA HOTAIR Is a Prognostic Marker for Esophageal Squamous Cell Carcinoma Progression and Survival
por: Lv, Xiao-Bin, et al.
Publicado: (2013)

BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors
por: Reithmeier, Thomas, et al.
Publicado: (2010)

TSPAN4 is a prognostic and immune target in Glioblastoma multiforme
por: Zheng, Yue, et al.
Publicado: (2023)

Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme
por: Liu, Erheng, et al.
Publicado: (2023)

The APC/C and CK1 in the developing brain
por: Penas, Clara, et al.
Publicado: (2015)

An RNA matchmaker protein regulates the activity of the long noncoding RNA HOTAIR
por: Meredith, Emily K., et al.
Publicado: (2016)

Prognostic significance of long noncoding RNA HOTAIR in hepatocellular carcinoma: A protocol for systematic review and meta-analysis
por: Feng, Lei, et al.
Publicado: (2022)

Anti-Tumor Functions of Prelatent Antithrombin on Glioblastoma Multiforme Cells
por: Peñas-Martínez, Julia, et al.
Publicado: (2021)

Prognostic significance of contactin 3 expression and associated genes in glioblastoma multiforme
por: Zhu, Yi-Fang, et al.
Publicado: (2019)

Prognostic Factors of Survival in Glioblastoma Multiforme Patients—A Retrospective Study
por: Șerban, Georgiana, et al.
Publicado: (2022)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017)

Prion Protein in Glioblastoma Multiforme
por: Ryskalin, Larisa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kpk2oqu0g7nuu998kj3bbje5s6